ForeverLabs
ServicesProvidersScienceMission
Schedule your free consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Autologous Stem Cells
diana-hauan-oFK7xgf4_50-unsplash.jpg
Blog
Mar 12, 2026
1 min read
Women in Stem Cell Research: The Visionaries Redefining Regenerative Medicine
From CRISPR to cord blood, explore how six women are pioneering and moving medicine toward a proactive, evidence-based future of recovery.
Hematopoietic Stem CellsAutologous Stem CellsParkinson DiseaseStem Cell Differentiation
wyoming-state-photo
Regulatory
Feb 17, 2026
1 min read
What you need to know about Senate File 48, Wyoming’s proposed Stem Cell Freedom Act
Wyoming’s Senate File 48, the Stem Cell Freedom Act, proposes a legal framework for physicians to perform autologous stem cell therapies under IRB oversight and cGMP safety standards.
BlogStem Cell Freedom Actright-to-tryAutologous Stem CellsMesenchymal stem cells
helena-lopes-e3OUQGT9bWU-unsplash.jpg
Blog
Jan 23, 2026
1 min read
2026: The Year of Longevity and Owning your Biology
Explore Forever Labs's outlook on 2026 trends in regenerative medicine. Longevity has transitioned from biohacking to a mainstream standard of care. Discover breakthroughs in "bio-liquidity", MSC priming, and epigenetic resetting, alongside regulatory shifts in the United States empowering patients to own their biology.
blogstem-cell-therapyAutologous Stem CellsMesenchymal stem cellsAging

Stay in touch

Shop

Annual planLifetime planClient LoginScheduler Login

Learn

ArticlesBlogPodcastFAQ

Careers

About usPrivacy policyPressTerms of Use

Questions

For physiciansPartner with usCareersContact us(888) 732-2375
ForeverLabs

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.